melanoma – Der Lab

February 28, 2018October 10, 2018 vdoyle099 Channing J. Der, ERK, FDA, melanoma, Merck, Non-small cell lung cancer, Novartis

Merck’s ERK inhibitor shows promise in combo against resistant cancers

by Amirah Al Idrus | Feb 22, 2018 fiercebiotech.com One-fifth of patients in a phase 1 study responded to an investigational ERK inhibitor from Merck, bolstering hopes that this type of drug could be used effectively in combination with other cancer drugs. ERK is a cell signal that is believed to drive the growth of … Continue reading Merck’s ERK inhibitor shows promise in combo against resistant cancers

February 16, 2015February 16, 2015 admin Der lab, grant, lab, Meagan Ryan, melanoma, NIH, pancreatic cancer, UNC, UNC Lineberger

Meagan Ryan Awarded a NIH F31 grant

Meagan Ryan, of the Der and Cox labs, was recently awarded a NIH fellowship grant (F31) for her application entitled "Defining the Role of ERK1 and ERK2 in pancreatic cancer". The current focus of Ryan's research is ERK1/2 signalling in pancreatic cancer and melanoma. Well done Meagan!